About CoapTech
CoapTech is a Healthcare company based in Baltimore (United States) founded in 2016. Minimally invasive gastrostomy feeding tube placement method is developed. CoapTech has raised $16.52 million across 11 funding rounds from investors including NIH, HHS and TEDCO. CoapTech offers products and services including PUMA-G System and PUG Procedure. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include EndoGastric Solutions, EndoChoice and Reliefband; 3 of its 3 listed competitors have raised funding.
Company details
CoapTech was founded in 2016 in Baltimore, United States, within the medical device sector. A minimally invasive approach for gastrostomy feeding tube placement is provided through the PUMA-G system and the percutaneous ultrasound gastrostomy (PUG) procedure. Magnetic components are employed, including one affixed to an inserted catheter and another for external guidance and control. Operations focus on enhancing patient outcomes in gastrointestinal interventions.
- Headquarters Baltimore, United States
- SectorsHealthcare
- Website coaptech.com
- Social LinkedIn X
- Total Equity Funding$16.52M (USD)
in 11 rounds
- Latest Funding Round$7.07M (USD), Series B
Aug 2024
- InvestorsNIH
& 6 more
Products & Services of CoapTech
CoapTech offers a comprehensive portfolio of products and services, including PUMA-G System and PUG Procedure.
Ultrasound-based solution for bedside feeding tube placement to enhance safety.
Method for percutaneous ultrasound gastrostomy to reduce hospital stay lengths.
Funding Insights of CoapTech
CoapTech has successfully raised a total of $16.52M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $7.07 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.52M
- Total Rounds 11
- Last Round Series B — $7.07M
- First Round $1.46M
(Sep 2017)
- Investors Count 7
Latest 10 of 11 funding rounds of CoapTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $7.07M | Series B | – | – | – |
| Jul 2023 | $4M | Debt – Conventional | – | – | – |
| Apr 2023 | $785,000 | Debt – Conventional | – | – | – |
| Sep 2020 | Debt – Conventional | – | – | – | |
| Sep 2020 | $7.05M | Series B | – | Hunniwell Lake Ventures | – |
| Sep 2019 | $1.77M | Grant | – | – | |
| Aug 2019 | $1.2M | Grant | – | – | |
| Jul 2018 | $2.4M | Seed | – | – | |
| Jun 2018 | $225,000 | Grant | – | – | |
| Jun 2018 | $200,000 | Grant | – | – |
7 investors in total: 7 institutional.
Investors in CoapTech
CoapTech has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| hunniwell.com | ||||
Venture capital fund and startup accelerator programs focused on seed and early stage companies | 1998 | tedcomd.com | Columbia, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Research and health information on diabetes and kidney diseases are provided by NIDDK. | 1950 | niddk.nih.gov | United States | |
Supports technology commercialization, licensing, and partnerships for university innovations. | 2012 | umventures.org | Baltimore, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Funding is provided for technology product development in Maryland. | 1987 | mips.umd.edu | College Park, United States |
Investor details for CoapTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CoapTech
8 people are tracked at CoapTech (6 in leadership, 2 in board & advisors).
| Name | Role | Group |
|---|---|---|
Jared Wineberg | Senior Vice President Of Engineering | Leadership |
Noah Barasch | Director of Clinical R&D | Leadership |
Howard Carolan | Co-Founder & CEO | Leadership |
Steven Tropello | Founder & CMO | Leadership |
Jack Kent | Chief Commercialization Officer | Leadership |
Michelle Garner | Director Of Quality | Leadership |
Jeff Katz | Director | Board & advisors |
William Walker | Director | Board & advisors |
Complete people profiles for CoapTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CoapTech
3 dated milestones of CoapTech across 8 years, from founding to its latest funding, stage changes and deals.
- Founded CoapTech is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series B, of $7.1M.
Competitors of CoapTech
CoapTech has 3 listed competitors in our database, 3 of them funded. They include EndoGastric Solutions, EndoChoice and Reliefband.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endogastricsolutions.com | 2002 | San Mateo, United States | $355.2M | 80 | Incisionless transoral procedures for upper GI diseases are developed. | |
| endochoice.com | 2008 | Alpharetta, United States | $115.96M | 414 | Devices, systems, and services are provided for GI specialists. | |
| reliefband.com | 2015 | Chicago, United States | $6M | 10 | Wearable device is developed for nausea and vomiting relief. |
Detailed competitors of CoapTech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CoapTech
The website of CoapTech (coaptech.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 61.7% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as CoapTech (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Coaptech
Complete news archive for CoapTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoapTech
CoapTech was founded in 2016 and raised its 1st funding round 1 year after it was founded.
CoapTech is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
CoapTech is a funded company, having raised a total of $16.52M across 11 funding rounds to date. The company's 1st funding round was a Grant of $225K, raised on Sep 2017.
CoapTech was founded in 2016 in Baltimore, United States, within the medical device sector. A minimally invasive approach for gastrostomy feeding tube placement is provided through the PUMA-G system and the percutaneous ultrasound gastrostomy (PUG) procedure. Magnetic components are employed, including one affixed to an inserted catheter and another for external guidance and control. Operations focus on enhancing patient outcomes in gastrointestinal interventions.
CoapTech's top competitors include EndoChoice, EndoGastric Solutions and Reliefband.
CoapTech offers PUMA-G System and PUG Procedure.
CoapTech has 7 investors. Key investors include NIH, HHS, TEDCO, Hunniwell Lake Ventures, and National Institute of Diabetes and Digestive and Kidney Diseases.